vimarsana.com

Page 19 - பல்கலைக்கழகம் ஆஃப் விஸ்கான்சின் மாடிசன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

More management measures lead to healthier fish populations

Credit: Chris Anderson/University of Washington Fish populations tend to do better in places where rigorous fisheries management practices are used, and the more measures employed, the better for fish populations and food production, according to a new paper published Jan. 11 in Nature Sustainability. The study, led by Michael Melnychuk of the University of Washington s School of Aquatic and Fishery Sciences, draws upon the expertise of more than two dozen researchers from 17 regions around the world. The research team analyzed the management practices of nearly 300 fish populations to tease out patterns that lead to healthier fisheries across different locations. Their findings confirmed, through extensive data analysis, what many researchers have argued for several years.

OSF HealthCare hires new doctor

OSF HealthCare hires new doctor Rockford Register Star ROCKFORD OSF HealthCare recently hired Dr. Alyssa Ceilesh to its staff. Ceilesh specializes in hematology and medical oncology with an office located at the Patricia D. Pepe Center for Cancer Care at OSF Saint Anthony Medical Center, 5666 E. State St. Ceilesh received her Bachelor of Science in Biology from the University of Wisconsin Madison and her Doctor of Osteopathic Medicine from Midwestern University Chicago College of Osteopathic Medicine. For appointments: 815-227-2273. Do Not Sell My Info / Cookie Policy

India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur

India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur Bharat Biotech, whose Covaxin vaccine has already received emergency use approval, has said that the trial of a nasal variant of Covid-19 vaccine could begin in Nagpur in the next two weeks. Bharat Biotech to submit a proposal to DCGI soon. advertisement (Representational image. Photo: AFP) A nasal Covid-19 vaccine could be a reality in India soon with Bharat Biotech, the Indian vaccine maker, all set to start phase 1 and 2 trials of a nasal vaccine at Gillurkar Multi Speciality Hospital in Nagpur.

Next big bet: Experts bullish on Bharat Biotech s upcoming nasal vaccine

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : This product is a monthly auto renewal product. Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds. To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.